Natural Product: NPC511063

Natural Product IDNPC511063
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
29781-81-5
IUPAC Name (2~{S},3~{R},4~{S},5~{S},6~{R})-2-decoxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey JDRSMPFHFNXQRB-LJIZCISZSA-N
Standard InCHI InChI=1S/C16H32O6/c1-2-3-4-5-6-7-8-9-10-21-16-15(20)14(19)13(18)12(11-17)22-16/h12-20H,2-11H2,1H3/t12-,13-,14+,15-,16+/m1/s1
SMILES CCCCCCCCCCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   320.22 Volume:   329.477
?
Van der Waals volume.
Dense:   0.972 LogP:   2.355
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.369
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.672
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   6.0
TPSA:   99.38
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   4.0 Rings:   1.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.423 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.39 Fsp3:   1.0
MCE-18:   18.5
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.318 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.019
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.001
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.399 Promiscuous compounds:   0.026

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.218 MDCK Permeability:   -4.758
Pgp-inhibitor:   0.001 Pgp-substrate:   0.242
PAMPA:   0.179
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.845
20% Bioavailability (F20%):   0.5 30% Bioavailability (F30%):   0.972
50% Bioavailability (F50%):   0.828

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.012 MRP1:   0.365
Plasma Protein Binding (PPB):   92.38% Volume Distribution (VD):   -0.237
Fu: 8.423%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.963
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.306
BSEP inhibitor:   0.101

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.922
CYP2C19-inhibitor:   0.001 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.999 CYP2C9-substrate:   0.002
CYP2D6-inhibitor:   0.223 CYP2D6-substrate:   0.033
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.997
HLM stability:   0.163
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.961 Half-life (T1/2):  1.367

ADMET: Toxicity

hERG Blockers:  0.087 hERG Blockers (10um):  0.514
Human Hepatotoxicity (H-HT):  0.473 Drug-induced Liver Injury (DILI):  0.473
AMES Toxicity:  0.334 Rat Oral Acute Toxicity:  0.043
Maximum Recommended Daily Dose:  0.024 Skin Sensitization:  0.993
Carcinogencity:  0.135 Eye Corrosion:  0.059
Eye Irritation:  0.916 Respiratory Toxicity:  0.219
Drug-induced Neurotoxicity:  0.026 Ototoxicity:  0.843
Hematotoxicity:  0.245 Drug-induced Nephrotoxicity:  0.644
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.071
A549 Cytotoxicity:  0.217 Hek293 Cytotoxicity:  0.083
BCF:   1.894
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.268
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.266
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.652
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20874 Tanacetum vulgare Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[25924515]
NPO20874 Tanacetum vulgare Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[37630407]
NPO20874 Tanacetum vulgare Species Asteraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO20874 Tanacetum vulgare Species Asteraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO20874 Tanacetum vulgare Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO20874 Tanacetum vulgare Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC511063 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC606861
1.0 High Similarity NPC607126
0.8333 Intermediate Similarity NPC233726
0.6585 Remote Similarity NPC155457
0.6486 Remote Similarity NPC124963
0.6279 Remote Similarity NPC13143
0.6279 Remote Similarity NPC294813
0.617 Remote Similarity NPC277570
0.6042 Remote Similarity NPC206601
0.5918 Remote Similarity NPC601155
0.5897 Remote Similarity NPC326533
0.5882 Remote Similarity NPC488690
0.5686 Remote Similarity NPC285003
0.5625 Remote Similarity NPC147292
0.5593 Remote Similarity NPC482018
0.5593 Remote Similarity NPC482015
0.5526 Remote Similarity NPC23134
0.549 Remote Similarity NPC12040
0.537 Remote Similarity NPC469469
0.5306 Remote Similarity NPC477750
0.5306 Remote Similarity NPC477763
0.5306 Remote Similarity NPC477757
0.5306 Remote Similarity NPC477762
0.5306 Remote Similarity NPC477755
0.5306 Remote Similarity NPC477753
0.5263 Remote Similarity NPC42503
0.5263 Remote Similarity NPC282143
0.5263 Remote Similarity NPC107914
0.5263 Remote Similarity NPC242073
0.5263 Remote Similarity NPC299781
0.5263 Remote Similarity NPC488689
0.5263 Remote Similarity NPC157193
0.5263 Remote Similarity NPC608193
0.5254 Remote Similarity NPC603467
0.5192 Remote Similarity NPC241265
0.5179 Remote Similarity NPC163812
0.5111 Remote Similarity NPC268243
0.5094 Remote Similarity NPC280367

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC511063 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5349 Remote Similarity NPD904 Phase 3

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data